According to the National Institute on Aging, Alzheimer’s disease currently affects approximately 4.5 million Americans. Alzheimer’s attacks and kills brain cells leading to memory problems in its earliest stages and dementia in the latter stages.  The disease is currently without a cure.

Previous research identified a protein that leads to the plaque associated with Alzheimer’s progression. Purdue researchers have designed molecules that bind to and inhibit the activity of the protein. This research provides a platform for new drug discoveries which could not only stop the progression of Alzheimer’s, but possibly lead to some recovery of a patient’s cognitive abilities as well.

This technology is exclusively licensed to CoMentis, Inc.